| |||||||||||||||||||
| Mice harboring the CAG-luc-eGFP L2G85 transgene exhibit widespread expression of firefly luciferase and enhanced green fluorescence protein directed by the CAG promoter (human cytomegalovirus immediate early promoter enhancer with chicken beta-actin/rabbit beta-globin hybrid promoter). Transgene expression is reported in all tissues and organs, except mature erythrocytes. These CAG-luc-eGFP L2G85 transgenic mice may be useful in studies of transplantation, noninvasive lineage mapping, fluorescent and in vivo biolouminescence imaging and technology development. | |||||||||||||||||||
Type Coisogenic; Mutant Strain; Transgenic; Additional information on Genetically Engineered and Mutant Mice. Visit our online Nomenclature tutorial. Mating System Homozygote x Homozygote (Female x Male) 27-OCT-09 Species laboratory mouse Generation N21+ (10-JUL-09) Donating Investigator Christopher Contag, Stanford University Description
Mice homozygous for the CAG-luc-eGFP L2G85 transgene are viable and fertile, with widespread expression of firefly luciferase and enhanced green fluorescence protein directed by the CAG promoter (human cytomegalovirus immediate early promoter enhancer with chicken beta-actin/rabbit beta-globin hybrid promoter). Transgene expression is reported in all tissues and organs, except mature erythrocytes. Homozygotes have no reported gross physical or behavioral abnormalities. Following luciferin injection, luciferase expression is generally greater in males than females. These CAG-luc-eGFP L2G85 transgene may be useful in studies of transplantation, noninvasive lineage mapping, fluorescent and in vivo biolouminescence imaging and technology development.Development
The CAG-luc-eGFP transgenic construct was designed by the laboratory of Dr. Christopher H. Contag (Stanford University School of Medicine). Specifically, the transgene contained the human cytomegalovirus immediate early promoter enhancer with chicken beta-actin/rabbit beta-globin hybrid promoter (CAG; from the pCAGGS vector) upstream of a modified firefly luciferase gene open reading frame, 54 bp of the foot and mouth disease virus (FMDV) 2A sequence (ribsome slippage site), 24 bp polylinker, and enhanced Green Fluorescent Protein (eGFP) open reading frame. This transgene was injected into fertilized FVB mouse eggs. Founder line L2G85 animals were bred to wildtype FVB mice. These FVB-L2G85 (or FVB.luc) transgenic were then backcrossed to FVB for 20 generations prior to arrival at The Jackson Laboratory. Upon arrival, CAG-luc-eGFP transgenic mice were bred with FVB/NJ inbred mice (Stock No. 001800) for at least one generation to establish the colony.
| Control | ||
|---|---|---|
| 001800 FVB/NJ | ||
| Considerations for Choosing Controls | ||
Fluorescent Protein Strains
View Fluorescent Protein Strains (225 strains)
Strains carrying other alleles of ACTB
View Strains carrying other alleles of ACTB (35 strains)
Strains carrying other alleles of GFP
View Strains carrying other alleles of GFP (117 strains)
Strains carrying other alleles of luc
006100 B10.Cg-H2k Tg(NFkB/Fos-luc)26Rinc/J 006102 B10.Cg-H2k Tg(Il2/NFAT-luc)83Rinc/J 005999 B6(SJL)-Tg(SBE/Tk-luc)7Twc/J 003479 B6.C3-Tg(Fos-luc)1Rnd/J 006098 B6.Cg-Tg(Il2/NFAT-luc)83Rinc/J 006851 B6.Cg-Tg(Per1-luc)025Jt/J 006101 B6.Cg-Tg(TRE/Prl-luc)31FlvRinc/J 002709 B6;C3-Tg(TettTALuc)1Dgs/J 009638 FVB-Tg(GFAP-luc,GAPDH-rluc)172.9Mes/J 005125 FVB.129S6(B6)-Gt(ROSA)26Sortm1(Luc)Kael/J 002060 FVB/N-Tg(HIV-luc)326Morr/J 007800 FVB/N-Tg(Ins1-luc)VUPwrs/J 003275 STOCK Tg(tetL)1Bjd/J 003274 STOCK Tg(tetNZL)2Bjd/J View Strains carrying other alleles of luc (14 strains)
Strains carrying other alleles of CMV
006054 B6.C-Tg(CMV-cre)1Cgn/J 008301 B6.Cg-Tg(CMV-Klc1)90Gsn/J 007237 B6.Cg-Tg(CMV-Serpine1)1Dgi/J 003465 BALB/c-Tg(CMV-cre)1Cgn/J 006362 C57BL/6J-Tg(CMV-Cox8a/EYFP)17J/J 006439 FVB-Tg(tetO/CMV-KRAS*G12C)9.1Msmi/J 004375 FVB/N-Tg(tetO-Kras2)12Hev/J 002471 STOCK Tg(hCMV-cre)140Sau/J View Strains carrying other alleles of CMV (8 strains)
Fluorescent Proteins/lacZ Systems
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:
GFP relatedResearch Tools
Cancer Research
xenograft/transplant host
Developmental Biology Research
transplantation marker for embryonic and adult tissue
Fluorescent Proteins
Genetics Research
Tissue/Cell Markers: cell marker for bone marrow transplantation
Tissue/Cell Markers: multiple
Reproductive Biology Research
spermatogonial transplantation marker
transplantation marker for embryonic and adult tissue
Toxicology Research
B and T cell deficiency, xenograft transplant host
xenograft/transplant host
Research Tools
Fluorescent Proteins
| Allele Symbol | Tg(CAG-luc,-GFP)L2G85Chco | ||
|---|---|---|---|
| Allele Name | transgene insertion L2G85, Christopher H Contag | ||
| Allele Type | Transgenic (Reporter) | ||
| Common Name(s) | L2G85; luc+; | ||
| Mutation Made By | Ryan McBride Spitler, Stanford University | ||
| Strain of Origin | FVB | ||
| Expressed Gene | luc, luciferase, firefly | ||
| Expressed Gene | GFP, Green Fluorescent Protein, jellyfish | ||
| Green Fluorescent Protein (GFP), derived from the jellyfish Aequorea victoria, is a versatile reporter molecule which has found use in many biological applications. In some constructs the original molecule has been modified in order to enhance its fluorescence intensity (EGFP, enhanced GFP). When utilized in a transgenic construct, tissue expressing sufficient amounts of GFP will fluoresce when exposed to a 488 nm light source. | |||
| Promoter | CMV, cytomegalovirus, human | ||
| Promoter | ACTB, actin, beta, chicken | ||
| Molecular Note | A transgenic construct containing a modified firefly luciferase gene open reading frame, 54bp of the foot and mouth disease virus (FMDV) 2A sequence (ribsome slippage site) and eGFP sequence under the control of the chicken beta actin promoter coupled with the cytomegalovirus (CMV) immediate early enhancer (CAG), was injected into fertilized FVB mouse eggs. Founder line L2G85 animals were bred to wildtype FVB mice. [MGI Ref ID J:148234] | ||
| Gene Symbol and Name | Tg(CAG-luc,-GFP)L2G85Chco, transgene insertion L2G85, Christopher H Contag | ||
| Chromosome | UN | ||
| Gene Common Name(s) | L2G85; luc+; | ||
Genotyping Protocols
Fluorescent Proteins (Generic GFP), Melt Curve Analysis
Fluorescent Proteins -- Generic GFP, QPCR
Helpful Links
Genotyping resources and troubleshooting
Cao YA; Wagers AJ; Beilhack A; Dusich J; Bachmann MH; Negrin RS; Weissman IL; Contag CH. 2004. Shifting foci of hematopoiesis during reconstitution from single stem cells. Proc Natl Acad Sci U S A 101(1):221-6. [PubMed: 14688412] [MGI Ref ID J:148234]
Sheikh AY; Lin SA; Cao F; Cao Y; van der Bogt KE; Chu P; Chang CP; Contag CH; Robbins RC; Wu JC. 2007. Molecular imaging of bone marrow mononuclear cell homing and engraftment in ischemic myocardium. Stem Cells 25(10):2677-84. [PubMed: 17628019] [MGI Ref ID J:148235]
Tg(CAG-luc,-GFP)L2G85Chco relatedCreusot RJ; Yaghoubi SS; Chang P; Chia J; Contag CH; Gambhir SS; Fathman CG. 2009. Lymphoid-tissue-specific homing of bone-marrow-derived dendritic cells. Blood 113(26):6638-47. [PubMed: 19363220] [MGI Ref ID J:152743]
Fernandez I; Zeiser R; Karsunky H; Kambham N; Beilhack A; Soderstrom K; Negrin RS; Engleman E. 2007. CD101 surface expression discriminates potency among murine FoxP3+ regulatory T cells. J Immunol 179(5):2808-14. [PubMed: 17709494] [MGI Ref ID J:151833]
Zeiser R; Youssef S; Baker J; Kambham N; Steinman L; Negrin RS. 2007. Preemptive HMG-CoA reductase inhibition provides graft-versus-host disease protection by Th-2 polarization while sparing graft-versus-leukemia activity. Blood 110(13):4588-98. [PubMed: 17827390] [MGI Ref ID J:149097]
Colony Maintenance
Breeding & Husbandry When maintaining a live colony, these mice can be bred as homozygotes. Mating System Homozygote x Homozygote (Female x Male) 27-OCT-09 Diet Information LabDiet® 5K52/5K67
This strain is currently Under Development for Production.
To register your interest in this strain go to the Strain Interest Form.
Estimated Available for Sale Date: 07-DEC-09
Please note: Estimated available for sale dates are provided to keep customers better informed on strains under development. Please note that our Colony Managers routinely monitor the target date and edit it based on breeding performance and other factors. The length of time it takes to make a new strain available for sale depends on genotype, age, number of animals sent by the Donating Investigator, breeding performance, additional strain development (backcrossing, making homozygous), and anticipated demand for the strain/interest registered.
View All Strains Under Development and On Hold
| Standard Supply | Under Development for Distribution Colony |
|---|---|
| Supply Notes |
|
| Control | ||
|---|---|---|
| 001800 FVB/NJ | ||
| Considerations for Choosing Controls | ||
| USA, Canada and Mexico - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| International - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 1-800-422-6423 or 1-207-288-5845
Fax: 1-207-288-6150
Technical Support Email Form
For Licensing and Use Restrictions view the link(s) below:
- Use of MICE by companies or for-profit entities requires a license prior to shipping.
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of mice, products or services, JACKSON will, at its option, provide credit or replacement for the mice or product received or the services provided.
In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. In purchasing or receiving MICE, PRODUCTS or services from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.
MICE and PRODUCTS are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or services. In addition, special terms and conditions of sale of certain MICE, PRODUCTS or services may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and services by JACKSON, and by its licensees and distributors.
Acceptance of delivery of MICE, PRODUCTS or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or services by JACKSON.